Amphetamine positive urine toxicology screen secondary to atomoxetine

Joshua L Fenderson, Amy N Stratton, Jennifer S Domingo, Gerald O Matthews, Christopher D Tan

Research output: Contribution to journalArticlepeer-review


The aim of this paper is to report the first case of atomoxetine leading to false-positive urine drug screen. An otherwise healthy 27-year-old female with a history of attention deficit hyperactivity disorder (ADHD) treated with atomoxetine had an acute onset tonic-clonic seizure. On arrival to the hospital, a urine toxicological drug screen with immunochemical cloned enzyme donor immunoassay (CEDIA) was performed. Results were positive for amphetamines; however, the presence of these substances could not be confirmed with urine gas chromatography-mass spectrometry (GC-MS). She denied any illicit drug use, herbal medications, or supplements, and her other prescription medications have not been previously known to cause a false-positive result for amphetamines. While stimulant treatments for ADHD could certainly result in a positive result on urine screen for amphetamines, there have been no reports of false-positive results for amphetamines secondary to patients using atomoxetine. We implicate atomoxetine, and/or its metabolites, as a compound or compounds which may interfere with urine drug immunoassays leading to false-positive results for amphetamines CEDIA assays.

Original languageEnglish
Pages (from-to)381261
JournalCase reports in psychiatry
StatePublished - 2013


Dive into the research topics of 'Amphetamine positive urine toxicology screen secondary to atomoxetine'. Together they form a unique fingerprint.

Cite this